Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Cazzola

Showing results (131-140 of 802) with videos related to

Pageof 81
Sort By:
Family Practice|January 26, 2022
Medical knowledge about COVID-19 is travelling at the speed of mistrust: why this is relevant to primary careTharmegan Tharmaratnam, Anthony D'Urzo, Mario Cazzola
American Journal of Respiratory and Critical Care Medicine|November 8, 2023
Pharmacological Interpretation of the Efficacy of Ensifentrine in Chronic Obstructive Pulmonary Disease: Insights from ENHANCE TrialsLuigino Calzetta, Mario Cazzola, Paola Rogliani
Hematology. American Society of Hematology. Education Program|December 14, 2011
Myelodysplastic/myeloproliferative neoplasmsMario Cazzola, Luca Malcovati, Rosangela Invernizzi
Journal of the American College of Cardiology|May 4, 2019
Cardiovascular Disease in Chronic Respiratory Disorders and BeyondPaola Rogliani, Mario Cazzola, Luigino Calzetta
Respiratory Medicine|October 15, 2025
Treatable Traits. Why, What, How?Alvar Agusti, Peter Gibson, Mario Cazzola
International Journal of Chronic Obstructive Pulmonary Disease|March 6, 2025
Mucolytic Therapy in COPD: Patient Usage and Preferences in Real-World Italian SettingsSalvatore D'Antonio, Alfio Pennisi, Mario Cazzola
International Journal of Chronic Obstructive Pulmonary Disease|September 14, 2023
Can Treatable Traits Be the Approach to Addressing the Complexity and Heterogeneity of COPD?Mario Cazzola, Paola Rogliani, Francesco Blasi
The Lancet. Respiratory Medicine|April 2, 2018
Is ICS-LAMA an alternative option to treat patients with COPD?Paola Rogliani, Luigino Calzetta, Mario Cazzola
Blood|November 20, 2012
Biologic and clinical significance of somatic mutations of SF3B1 in myeloid and lymphoid neoplasmsMario Cazzola, Marianna Rossi, Luca Malcovati, et al.
Respiratory Medicine|January 1, 2008
Bacterial extracts for the prevention of acute exacerbations in chronic obstructive pulmonary disease: a point of viewMario Cazzola, Paola Rogliani, Giacomo Curradi
Pageof 81

Showing results (131-140 of 802) with videos related to

Sort By:
Pageof 81
Family Practice|January 26, 2022
Medical knowledge about COVID-19 is travelling at the speed of mistrust: why this is relevant to primary careTharmegan Tharmaratnam, Anthony D'Urzo, Mario Cazzola
American Journal of Respiratory and Critical Care Medicine|November 8, 2023
Pharmacological Interpretation of the Efficacy of Ensifentrine in Chronic Obstructive Pulmonary Disease: Insights from ENHANCE TrialsLuigino Calzetta, Mario Cazzola, Paola Rogliani
Hematology. American Society of Hematology. Education Program|December 14, 2011
Myelodysplastic/myeloproliferative neoplasmsMario Cazzola, Luca Malcovati, Rosangela Invernizzi
Journal of the American College of Cardiology|May 4, 2019
Cardiovascular Disease in Chronic Respiratory Disorders and BeyondPaola Rogliani, Mario Cazzola, Luigino Calzetta
Respiratory Medicine|October 15, 2025
Treatable Traits. Why, What, How?Alvar Agusti, Peter Gibson, Mario Cazzola
International Journal of Chronic Obstructive Pulmonary Disease|March 6, 2025
Mucolytic Therapy in COPD: Patient Usage and Preferences in Real-World Italian SettingsSalvatore D'Antonio, Alfio Pennisi, Mario Cazzola
International Journal of Chronic Obstructive Pulmonary Disease|September 14, 2023
Can Treatable Traits Be the Approach to Addressing the Complexity and Heterogeneity of COPD?Mario Cazzola, Paola Rogliani, Francesco Blasi
The Lancet. Respiratory Medicine|April 2, 2018
Is ICS-LAMA an alternative option to treat patients with COPD?Paola Rogliani, Luigino Calzetta, Mario Cazzola
Blood|November 20, 2012
Biologic and clinical significance of somatic mutations of SF3B1 in myeloid and lymphoid neoplasmsMario Cazzola, Marianna Rossi, Luca Malcovati, et al.
Respiratory Medicine|January 1, 2008
Bacterial extracts for the prevention of acute exacerbations in chronic obstructive pulmonary disease: a point of viewMario Cazzola, Paola Rogliani, Giacomo Curradi
Pageof 81